ArticleScientific reports2025
Advancing the accuracy of tyrosinase inhibitory peptides prediction via a multiview feature fusion strategy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- NToxSEM: Enhancing prediction of neurotoxic peptides and neurotoxins using a stacked ensemble-based multimodal framework.Protein science : a publication of the Protein Society · 2026Article
- Leveraging a Meta-Learning Strategy to Advance the Accuracy of Neutralizing Antibodies against Dengue Virus Serotype Prediction.ACS omega · 2025Article
- Identifying protein succinylation sites using generative transformer and a two-dimensional representation with a deep capsule network.iScience · 2025Article
- PCBert-Kla: an efficient prediction method for lysine lactylation sites based on ProtBert and fusion of physicochemical features.Briefings in bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Tyrosinase plays a crucial role as an enzyme in the production of melanin, which is the pigment accountable for determining the color of the hair, eyes, and skin. Tyrosinase inhibitory peptides (TIPs), mainly designed to regulate the activity of the enzyme tyrosinase, are of interest in various domains, including cosmetics, dermatology, and pharmaceuticals, due to their potential applications in controlling skin pigmentation. To date, a few machine learning-based models have been proposed for predicting TIPs, but their predictive performance remains unsatisfactory. In this study, we propose an innovative computational approach, named TIPred-MVFF, to accurately predict TIPs using only sequence information. Firstly, we established an up-to-date and high-quality dataset by collecting samples from various sources. Secondly, we applied a multi-view feature fusion (MVFF) strategy to extract and explore probability and category information embedded in TIPs, employing several machine learning (ML) algorithms coupled with different commonly used sequence-based feature encodings. Then, we employed resampling approaches to address the class imbalance issue. Finally, to maximize the utility of each feature, we fused probability-based and sequence-based features, generating more informative feature that were used to develop the final prediction model. Based on the independent test, experimental results showed that TIPred-MVFF outperformed several conventional ML classifiers and existing methods in terms of prediction accuracy and robustness, achieving an accuracy of 0.937 and a Matthew's correlation coefficient of 0.847. This new computational approach is anticipated to aid community-wide efforts in rapidly and cost-effectively discovering novel peptides with strong tyrosinase inhibitory activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.